Bubendorf, Switzerland, Friday, November 1, 2019 - Within the scope of the proof-of-concept study at the Paul Scherer Institute, a number of polymer-drug carriers enabling the conjugation of different amounts [...]
Baden, Switzerland, Tuesday, October 29, 2019 - CIS Pharma and the University of Applied Sciences, FHNW Muttenz, are giving a talk at the Nano-Tech Apèro of the Swiss Nanoscience Institute, [...]
Bubendorf, Switzerland, Wednesday, September 5, 2019 - CIS Pharma has signed a research agreement with the Paul Scherer Institute, Switzerland. The program comprises an invitro and invivo program for the [...]
Schaffhausen, Switzerland, Friday, July 19, 2019 - During our Summer Event we take a boat ride along the banks of the Rhine Falls in Schaffhausen. The spectacular falls offers a [...]
Bubendorf, Switzerland, Thursday, April 25, 2019 - In a new research program the surface of PEEK medical implants will modified to enhance osteointegration and soft-tissue compatibility. The modification is targeting the [...]
Bern, Switzerland, Friday, December 7, 2018 - For the end of year event, the team of CIS Pharma sets out to Bern, the capital of Switzerland. Our city guide Domenico [...]
Bubendorf, Switzerland, Thursday, November 22, 2018 - CIS Pharma has identified the group of Prof. Schibli and Dr. Behe from the Paul Scherer Institute, ETH, as potential partners for its [...]
Basel, Switzerland, Tuesday, September 11, 2018 - During our Summer Event we dive into the multifaceted side of Basel, Kleinbasel, at the northern banks of the river Rhine. Our trip [...]
Bubendorf, Switzerland, Friday, August 30, 2018 – CIS Pharma announces the approval of a vial adaptor specific for the preparation and injection of intracameral cefuroxime. Consequently, the adaptor was produced [...]
Bubendorf, Switzerland, Tuesday, July 10, 2018 - Over the course of the past months, CIS Pharma has developed concepts and strategies to conjugate radioisotopes onto its polymer-drug carriers. First syntheses [...]